Cargando…
Organoid-based regenerative medicine for inflammatory bowel disease
Inflammatory bowel disease (IBD) consists of two major idiopathic gastrointestinal diseases: ulcerative colitis and Crohn's disease. Although a significant advance has been achieved in the treatment of IBD, there remains a particular population of patients that are refractory to the conventiona...
Autores principales: | Okamoto, Ryuichi, Shimizu, Hiromichi, Suzuki, Kohei, Kawamoto, Ami, Takahashi, Junichi, Kawai, Mao, Nagata, Sayaka, Hiraguri, Yui, Takeoka, Sayaka, Sugihara, Hady Yuki, Yui, Shiro, Watanabe, Mamoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society for Regenerative Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961757/ https://www.ncbi.nlm.nih.gov/pubmed/31970266 http://dx.doi.org/10.1016/j.reth.2019.11.004 |
Ejemplares similares
-
Suspension culture in a rotating bioreactor for efficient generation of human intestinal organoids
por: Takahashi, Junichi, et al.
Publicado: (2022) -
Notch and TNF-α signaling promote cytoplasmic accumulation of OLFM4 in intestinal epithelium cells and exhibit a cell protective role in the inflamed mucosa of IBD patients
por: Kuno, Reiko, et al.
Publicado: (2021) -
Single cell analysis of Crohn’s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties
por: Suzuki, Kohei, et al.
Publicado: (2018) -
Protocol to generate large human intestinal organoids using a rotating bioreactor
por: Takahashi, Junichi, et al.
Publicado: (2023) -
Collagen type I-mediated mechanotransduction controls epithelial cell fate conversion during intestinal inflammation
por: Kobayashi, Sakurako, et al.
Publicado: (2022)